intravenous infusion of furosemide (doses 125-250mg⁄ bid) from the first day after admission until 3 days before discharge Intervention: drug: furosemide ; other name: lasix

small volumes of hypertonic saline solutions (HSS) (150mL 1.4-4.6% NaCl), from the first day after admission until 3 days before discharge Intervention: Hypertonic saline solutions (1.4-4.6%NaCl) Intervention other name: not specified

no intervention Intervention: no drug only seriated paracentesis repeated paracentesis from the first day after admission until 3 days before discharge

Ascites

Cirrhosis

treatment with intravenous infusion of furosemide (doses 125-250mg⁄ bid) plus small volumes of HSS (150mL 1.4-4.6% NaCl), from the first day after admission until 3 days before discharge, with water restriction and a normal sodium diet.

intravenous furosemide

Intravenous small volumes of HSS (150mL 1.4-4.6% NaCl), plus treatment with intravenous infusion of furosemide (doses 125-250mg⁄ bid) from the first day after admission until 3 days before discharge, with water restriction and a normal sodium diet.

Hypertonic saline solutions

repeated paracentesis from the first day after admission until 3 days before discharge

Seriated paracentesis

Antonino Tuttolomondo

Internal Medicine Ward of Palermo University Hospital

Internal Medicine Ward, University of Palermo

Metabolic Effects of Furosemide +HSS in Refractory Ascites

Immune-inflammatory and Metabolic Effects of High Dose Furosemide Plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects With Refractory Ascite

difference between ANP serum levels at admission and ANP serum levels at discharge.

difference between BNP serum levels at admission and BNP serum levels at discharge.

difference between IL-1 beta serum levels at admission and IL-1 beta serum levels

difference between serum visfatin at admission and serum visfatin at discharge.

difference between serum leptin at admission and serum leptin at discharge.

difference between serum TNF-alfa at admission and serum TNF-alfa at discharge.

difference between serum IL-6 at admission and serum Il-6 at discharge.

phoenix/albaiminí

Metabolic Effects of Furosemide +HSS in Refractory Ascites

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht